JPMorgan Chase & Co’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Sell |
69,279
-5,865
| -8% | -$42.1K | ﹤0.01% | 4074 |
|
|
2025
Q1 | $450K | Buy |
75,144
+13,684
| +22% | +$82K | ﹤0.01% | 4084 |
|
|
2024
Q4 | $479K | Sell |
61,460
-3,368
| -5% | -$26.3K | ﹤0.01% | 4173 |
|
|
2024
Q3 | $700K | Buy |
64,828
+5,720
| +10% | +$61.8K | ﹤0.01% | 3844 |
|
|
2024
Q2 | $498K | Sell |
59,108
-27,496
| -32% | -$232K | ﹤0.01% | 3859 |
|
|
2024
Q1 | $582K | Sell |
86,604
-36,590
| -30% | -$246K | ﹤0.01% | 3873 |
|
|
2023
Q4 | $724K | Sell |
123,194
-145,417
| -54% | -$855K | ﹤0.01% | 3708 |
|
|
2023
Q3 | $2.62M | Buy |
268,611
+1,953
| +0.7% | +$19K | ﹤0.01% | 2845 |
|
|
2023
Q2 | $3.16M | Sell |
266,658
-2,835
| -1% | -$33.6K | ﹤0.01% | 2774 |
|
|
2023
Q1 | $2.91M | Buy |
269,493
+28,073
| +12% | +$303K | ﹤0.01% | 2814 |
|
|
2022
Q4 | $2.79M | Buy |
241,420
+12,578
| +5% | +$145K | ﹤0.01% | 2756 |
|
|
2022
Q3 | $3.41M | Sell |
228,842
-127,066
| -36% | -$1.9M | ﹤0.01% | 2581 |
|
|
2022
Q2 | $3.21M | Buy |
355,908
+192,107
| +117% | +$1.73M | ﹤0.01% | 2701 |
|
|
2022
Q1 | $1.23M | Sell |
163,801
-52,644
| -24% | -$394K | ﹤0.01% | 3492 |
|
|
2021
Q4 | $1.86M | Buy |
216,445
+23,120
| +12% | +$198K | ﹤0.01% | 3278 |
|
|
2021
Q3 | $1.63M | Buy |
193,325
+24,104
| +14% | +$203K | ﹤0.01% | 3303 |
|
|
2021
Q2 | $1.37M | Sell |
169,221
-78,947
| -32% | -$641K | ﹤0.01% | 3448 |
|
|
2021
Q1 | $2.18M | Buy |
248,168
+180,954
| +269% | +$1.59M | ﹤0.01% | 3194 |
|
|
2020
Q4 | $755K | Buy |
+67,214
| New | +$755K | ﹤0.01% | 3523 |
|
|
2020
Q1 | – | Sell |
-60
| Closed | – | – | 4674 |
|
|
2019
Q4 | $0 | Buy |
+60
| New | – | ﹤0.01% | 4706 |
|
|
2019
Q2 | – | Sell |
-1,161
| Closed | -$20K | – | 4826 |
|
|
2019
Q1 | $20K | Sell |
1,161
-8,416
| -88% | -$145K | ﹤0.01% | 4502 |
|
|
2018
Q4 | $168K | Buy |
9,577
+4,389
| +85% | +$77K | ﹤0.01% | 3866 |
|
|
2018
Q3 | $213K | Buy |
5,188
+5,008
| +2,782% | +$206K | ﹤0.01% | 3850 |
|
|
2018
Q2 | $10K | Buy |
+180
| New | +$10K | ﹤0.01% | 4597 |
|